Behnaz Parhami-Seren

Title: Behnaz Parhami-Seren: Innovator in Monoclonal Antibodies

Introduction

Behnaz Parhami-Seren is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on creating innovative solutions for diagnostic and therapeutic applications.

Latest Patents

Behnaz Parhami-Seren holds a patent for "Ouabain-specific monoclonal antibodies." This invention relates to a monoclonal antibody or antigen binding fragment that has binding specificity for ouabain, ensuring that it does not cross-react with digoxin. The anti-ouabain monoclonal antibody can bind ouabain with an affinity of at least about 10M, which is a significant achievement in the field. The patent also discusses the diagnostic and therapeutic uses of these monoclonal antibodies.

Career Highlights

Behnaz Parhami-Seren is associated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has the potential to impact various medical applications, particularly in the treatment and diagnosis of conditions related to ouabain.

Collaborations

Some of her notable coworkers include Michael N Margolies and Garner T Haupert, Jr. Their collaborative efforts contribute to the advancement of research in monoclonal antibodies and related fields.

Conclusion

Behnaz Parhami-Seren is a pioneering inventor whose work in monoclonal antibodies is paving the way for new diagnostic and therapeutic solutions. Her contributions are vital to the ongoing advancements in biotechnology and medicine.